Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study
Titel:
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study
Auteur:
Schultheis, B. Folprecht, G. Kuhlmann, J. Ehrenberg, R. Hacker, U.T. Köhne, C.H. Kornacker, M. Boix, O. Lettieri, J. Krauss, J. Fischer, R. Hamann, S. Strumberg, D. Mross, K.B.